The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03364868
Recruitment Status : Active, not recruiting
First Posted : December 7, 2017
Last Update Posted : September 25, 2023
Helmholtz Zentrum München
University Hospital Carl Gustav Carus
Kinderkrankenhaus auf der Bult
Skane University Hospital
Universitaire Ziekenhuizen KU Leuven
Medical University of Warsaw
University of Oxford, Clinical Vaccine Research and Immunisation Education
Information provided by (Responsible Party):
Technical University of Munich